Development and validation of a cardiovascular risk prediction model for Japanese: The Hisayama study

Hypertension Research

Volumn 32, Issue 12, 2009, Pages 1119-1122

  Arima, Hisatomi ^a   Yonemoto, Koji ^a   Doi, Yasufumi ^a   Ninomiya, Toshiharu ^a   Hata, Jun ^a   Tanizaki, Yumihiro ^a   Fukuhara, Masayo ^a   Matsumura, Kiyoshi ^a   Iida, Mitsuo ^a   Kiyohara, Yutaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Cardiovascular disease; Epidemiology; Risk factors; Risk prediction model

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; JAPANESE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTION; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX; SMOKING; STROKE; SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE; VALIDATION STUDY;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS;

EID: 73849116112     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.161     Document Type: Article

References (25)

1. World Health Organization. The atlas of heart disease and stroke. World Health Organization: Geneva, 2004.
2. Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Arima H, Tanaka K, Nakamura H, Okubo K, Iida M. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke 2003; 34: 2349-2354.
3. World Health Organization. Preventing chronic disease: a vital investment. World Health Organization: Geneva, 2005.
4. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, for the SCORE Project Group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003.
5. NIPPON DATA 80 Research Group. Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population. Circ J 2006; 70: 1249-1255.
6. Wu Y, Liu X, Li X, Li Y, Zhao L, Chen Z, Rao X, Zhou B, Detrano R, Liu K, for the USA-PRC Collaborative Study of Cardiovascular and Cardiopulmonary Epidemiology Research Group and the Chine Multicenter Collaborative Study of Cardiovascular Epidemiology (China MUCA) Research Group. Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults. Circulation 2006; 114: 2217-2225.
7. Asia pacific Cohort Studies Collaboration. Cardiovascular risk prediction tools for populations in Asia. J Epidemiol Community Health 2007; 61: 115-121.
8. Mendis S, Lindholm LH, Mancia G, Whitworth J, Alderman M, Lim S, Heagerty T. World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. J Hypertens 2007; 25: 1578-1582.
9. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007; 297: 611-619.
10. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117: 743-753.
11. Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet 2008; 371: 923-931.
12. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, Brindle P. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. Br Med J 2008; 336: 1475-1482.
13. Teramoto T, Ohashi Y, Nakaya N, Yokoyama S, Mizuno K, Nakamura H, for the MEGA Study Group. Practical risk prediction tools for coronary heart disease in mild to moderate hypercholesterolemia in Japan: originated from the MEGA study data. Circ J 2008; 72: 1569-1575.
14. Matsumoto M, Ishikawa S, Kayaba K, Gotoh T, Nago N, Tsutsumi A, Kajii E, the Jichi Medical School (JMS) Cohort Study Group. Risk charts illustrating the 10-year risk of myocardial infarction among residents of Japanese rural communities: the JMS Cohort Study. J Epidemiol 2009; 19: 94-100.
15. Ishikawa S, Matsumoto M, Kayaba K, Gotoh T, Nago N, Tsutsumi A, Kajii E, the Jichi Medical School (JMS) Cohort Study Group. Risk charts illustrating the 10-year risk of stroke among residents of Japanese rural communities: the JMS Cohort Study. J Epidemiol 2009; 19: 101-106.
16. Kiyohara Y, Ueda K, Fujishima M. Smoking and cardiovascular disease in the general population in Japan. J Hypertens 1990; 8: S9-S15.
17. Arima H, Tanizaki Y, Kiyohara Y, Tsuchihashi T, Kato I, Kubo M, Tanaka K, Ohkubo K, Nakamura H, Abe I, Fujishima M, Iida M. Validity of the JNC VI recommendations for the management of hypertension in a general population of Japanese elderly: the Hisayama Study. Arch Intern Med 2003; 163: 361-366.
18. Arima H, Kiyohara Y, Kato I, Tanizaki Y, Kubo M, Iwamoto H, Tanaka K, Abe I, Fujishima M. Alcohol reduces insulin-hypertension relationship in a general population: the Hisayama study. J Clin Epidemiol 2002; 55: 863-869. (Pubitemid 35246556)
19. Arima H, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y, Hata J, Matsumura K, Iida M, Kiyohara Y. High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study. Arterioscler Thromb Vasc Biol 2008; 28: 1385-1391.
20. Doi Y, Kubo M, Yonemoto K, Ninomiya T, Iwase M, Arima H, Hata J, Tanizaki Y, Iida M, Kiyohara Y. Fasting plasma glucose cutoff for diagnosis of diabetes in a Japanese population. J Clin Endocrinol Metab 2008; 93: 3425-3429.
21. Imamura T, Doi Y, Arima H, Yonemoto K, Hata J, Kubo M, Tanizaki Y, Ibayashi S, Iida M, Kiyohara Y. LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population: the Hisayama study. Stroke 2009; 40: 382-388.
22. Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
23. Matsumoto M, Nishimura T. Mersenne Twister: a 623-dimensionally equidistributed uniform pseudorandom number generator. ACM Trans on Modeling and Computers Simulations 1998; 8: 3-30.
24. Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 2004; 23: 2109-2123.
25. Sullivan LM, Massaro JM, D'Agostino RB. Presentation of multivariate data for clinical use: the Framingham study risk score functions. Stat Med 2004; 23: 1631-1660.